Gilead Sciences, Inc P/B Ratio
Data as of August 04, 2026
P/B Ratio
7.17
Stock Price
$131.15
Book Value/Share
$18.29
Sector
Biotechnology
How It's Calculated
7.17 = $131.15 ÷ $18.29
What This Means
Gilead Sciences, Inc's P/B ratio of 7.17 is above 6. Asset-light business models and unrecognized intangible assets can make book value a limited denominator; the multiple alone does not determine fair value.
About Gilead Sciences, Inc
Gilead Sciences, Inc (GILD) operates in the Biotechnology sector, specifically in Biotechnology. With a market capitalization of about $161.66B, it ranks as a large-cap stock — a major established company.
Shares recently traded near $131.15, within a 52-week range of $108.46 to $157.29 (-16.6% from the high, +20.9% from the low). Beta of 0.34 indicates relatively lower volatility versus the market.
Trailing profit margin is about 31.0%, signaling a strong profit margin relative to many peers.
Understanding This Metric
The price-to-book ratio compares market price to net asset value per share. For Gilead Sciences, Inc, P/B is especially useful when earnings are volatile or temporarily depressed. In Biotechnology, asset-heavy business models often anchor closer to book value, while asset-light models may trade far above book.
Sector Comparison
Among Biotechnology names on our S&P 100 coverage, Gilead Sciences, Inc's P/B ratio of 7.17 can be compared with peers such as AMGN (23.58), REGN (2.57). Sector context helps interpretation, but each company's growth profile and balance sheet differ — use multiple metrics before drawing conclusions. View all Biotechnology stocks.
Key Takeaways
- GILD is grouped in the Biotechnology sector for peer comparisons.
- Recent beta of 0.34 suggests lower-than-market price sensitivity.
- Trailing profit margin of 31.0% provides context for how much earnings support the headline multiple.
Related Tools & Guides
Explore calculators and guides connected to this metric, or view all metrics for GILD.
Learn the full workflow
Compare PE with PB, PEG, EV/EBITDA, and market cap in one structured path.
Open the Stock Valuation hub →Other GILD Metrics
Frequently Asked Questions
What does GILD's price-to-book ratio indicate?
P/B compares share price to book value per share. Gilead Sciences, Inc's P/B of 7.17 reflects how the market prices net assets — especially relevant for asset-heavy Biotechnology business models.
Is 7.17 above or below book value?
A P/B above 1.0 (7.17) means the market values GILD above accounting book value — often due to brands, growth, or intangible assets.
How does P/B compare within Biotechnology?
Peer P/B levels in Biotechnology (e.g. AMGN (23.58), REGN (2.57)) provide context; asset-light vs asset-heavy models differ materially.
Calculate the p/b ratio for any stock with our free calculator.
Open P/B Ratio Calculator →